SBIO

ALPS Medical Breakthroughs ETFALPS Funds$54.79-0.13 (-0.24%)

AUM $180.0MER 0.50%NAV $52.18Holdings 103Inception Dec 2014

Price Chart

Key Statistics

Previous Close

$54.81

Day Range

$54.72$55.57

52-Week Range

$42.03$70.79

Avg Volume

39.5K

Dividend Yield

2.29%

Expense Ratio

0.50%

AUM

$180.0M

Shares Outstanding

3.4M

ETF Grades

?ETF Grades compare this fund against others in the same category using percentile rankings across six factors. Grades range from A+ (top 5%) to F (bottom 20%). Updated daily.

Sector Breakdown

Sector	Weight %
Healthcare	100.00%

Country Allocation

Country	Weight %
United States	89.13%
Canada	2.36%
United Kingdom	2.24%
China	1.84%
Netherlands	1.71%
Belgium	1.68%
Germany	0.72%
Switzerland	0.33%

Fund Information

Issuer: ALPS Funds
Category: Healthcare
Types: Healthcare
Inception Date: Dec 30, 2014
Exchange: NYSE_ARCA
Description: The ALPS Medical Breakthroughs ETF (SBIO) seeks investment results that correspond (before fees and expenses) generally to the performance of its underlying index, the S-Network Medical Breakthroughs Index (PMBI).

Similar ETFs

Symbol	Name	AUM	Expense Ratio	Holdings
XLV	State Street Health Care Select Sector SPDR ETF	$44.84B	0.08%	61
VHT	Vanguard Health Care ETF	$21.80B	0.09%	411
VTWO	Vanguard Russell 2000 ETF	$17.30B	0.06%	1,969
RWL	Invesco S&P 500 Revenue ETF	$10.09B	0.39%	504
XBI	State Street SPDR S&P Biotech ETF	$10.07B	0.35%	165

The ALPS Medical Breakthroughs ETF (SBIO) is an exchange-traded fund issued by ALPS Funds that launched on Dec 30, 2014. It currently manages $180.0M in assets under management. The fund charges an expense ratio of 0.50%. The fund holds 103 securities in its portfolio. It falls under the Healthcare category.

Top 10 holdings represent 30.6% of the fund

Rank	Symbol	Name	Weight %	Shares	Market Value
1	CGON	CG oncology Inc.	3.84%	111,786	$6.9M
2	TVTX	Travere Therapeutics Inc.	3.49%	118,866	$6.3M
3	ORKA	Oruka Therapeutics Inc.	3.43%	83,510	$6.2M
4	MANE	VeraDermics Inc.	3.37%	52,682	$6.1M
5	DFTX	Definium Therapeutics Inc.	3.22%	169,417	$5.8M
6	DNTH	Dianthus Therapeutics Inc.	2.92%	70,505	$5.3M
7	EWTX	Edgewise Therapeutics Inc.	2.91%	136,920	$5.2M
8	RLAY	Relay Therapeutics Inc.	2.66%	276,308	$4.8M
9	AMLX	Amylyx Pharmaceuticals Inc.	2.43%	158,281	$4.4M
10	ACAD	ACADIA Pharmaceuticals Inc.	2.38%	217,290	$4.3M
11	XENE	Xenon Pharmaceuticals Inc.	2.33%	122,095	$4.2M
12	IDYA	Ideaya Biosciences Inc.	2.29%	121,662	$4.1M
13	TARS	Tarsus Pharmaceuticals Inc.	2.18%	55,323	$3.9M
14	DNLI	Denali Therapeutics Inc.	2.05%	201,552	$3.7M
15	DYN	Dyne Therapeutics Inc.	2.00%	235,461	$3.6M

Page 1 of 3

Detailed Returns

Period	ETF	Cat. Avg
1D	-0.24%	—
1W	+6.58%	—
1M	-13.86%	—
3M	-14.43%	—
6M	+0.57%	—
YTD	+8.79%	—
1Y	+29.84%	—
3Y	+127.38%	—
5Y	+17.81%	—

Moving Averages

20-Day MA

$54.87

Below 20-Day MA

50-Day MA

$61.71

Below 50-Day MA

200-Day MA

$56.89

Below 200-Day MA

Price with Moving Averages

Support & Resistance

52-Week High

$70.79

Current Price

$54.79

52-Week Low

$42.03

$42.03$70.79

Current Yield

2.29%

Annual Dividend

$1.2764

Frequency

1x/year

Last Ex-Date

Dec 19, 2024

Dividend History

Ex-Date	Amount	Pay Date
Dec 19, 2024	$1.1735	Dec 26, 2024
Dec 21, 2023	$0.0711	Dec 27, 2023
Dec 19, 2019	$0.0160	Dec 27, 2019
Dec 19, 2019	$0.0158	Dec 27, 2019
Dec 20, 2018	$0.7841	Dec 27, 2018
Dec 20, 2018	$0.7840	Dec 27, 2018
Dec 21, 2017	$0.5795	Dec 28, 2017
Dec 21, 2017	$0.5790	Dec 28, 2017

Dividend Payments Over Time

Category Comparison

Metric	SBIO	Healthcare(205 ETFs)	Healthcare(24 ETFs)
Fund Info
Expense Ratio	0.50%	0.64%	0.47%
AUM	$180.0M	$868.4M	$819.3M
Dividend Yield	2.29%	4.50%	1.60%
Avg Volume	39.5K	264.1K	130.2K
Holdings	103	145	172
Performance
1-Month Return	-13.86%	-1.96%	+0.17%
6-Month Return	+6.88%	+10.01%	+10.55%
YTD Return	+6.54%	+11.25%	+8.99%
1-Year Return	+7.29%	+7.17%	+7.17%

Compare with Another ETF

Search for an ETF to compare with SBIO:

FREE DOWNLOAD

The Beginner's Guide to ETFs

20 pages. Zero fluff. Everything you need to start investing in ETFs.

No spam. Unsubscribe anytime.